Journal of Molecular Neuroscience

, Volume 59, Issue 1, pp 99–105

Silencing of Id2 Alleviates Chronic Neuropathic Pain Following Chronic Constriction Injury


DOI: 10.1007/s12031-016-0713-z

Cite this article as:
Jiang, L., Wu, Q. & Yang, T. J Mol Neurosci (2016) 59: 99. doi:10.1007/s12031-016-0713-z


Inhibitor of DNA binding/differentiation 2 (Id2) belongs to a helix-loop-helix family of proteins. Recent studies have showed that Id2 plays a pivotal role in neuronal survival and neuroprotection. However, under neuropathic pain conditions, the role of Id2 is still unclear. In this study, we investigated the effect of Id2 on neuropathic pain in a rat chronic constriction injury (CCI) model. Our results demonstrated that Id2 was upregulated in the dorsal root ganglion (DRG) in a CCI rat in a time-dependent manner. Intrathecal short-hairpin RNA (shRNA)-Id2 attenuates mechanical allodynia and thermal hyperalgesia in CCI rats, and inhibits the expression of TNF-α and IL-1β in the DRG in CCI rats. Furthermore, knockdown of Id2 reduces the expression of NF-κB p65 in the DRG of CCI rats. Taken together, our findings suggest that knockdown of Id2 may alleviate neuropathic pain by inhibiting the NF-κB activation to inhibit the production of pro-inflammatory mediators. Therefore, Id2 may provide an important target of neuropathic pain treatment.


Inhibitor of DNA binding/differentiation 2 (Id2) Neuropathic pain Chronic constriction injury (CCI) NF-ĸB 

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of AnesthesiologyThe First Affiliated Hospital of Wenzhou Medical UniversityWenzhouChina

Personalised recommendations